{{Rsnum
|rsid=9295740
|Gene=TRNAL16
|Chromosome=6
|position=27721723
|Orientation=plus
|GMAF=0.2691
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 18.6 | 77.0
| HCB | 4.4 | 32.8 | 62.8
| JPT | 2.7 | 33.6 | 63.7
| YRI | 34.7 | 44.2 | 21.1
| ASW | 19.3 | 40.4 | 40.4
| CHB | 4.4 | 32.8 | 62.8
| CHD | 5.5 | 20.2 | 74.3
| GIH | 2.0 | 29.7 | 68.3
| LWK | 38.2 | 44.5 | 17.3
| MEX | 3.4 | 36.2 | 60.3
| MKK | 35.3 | 45.5 | 19.2
| TSI | 3.9 | 31.4 | 64.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22404340
|Title=Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population
}}

{{PMID Auto
|PMID=17903294
|Title=Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=18978787
|Title=Common 5p15.33 and 6p21.33 variants influence lung cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=24039754
|Title=The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}